@BOEHRINGER 16 Sep 2016 at 17:05
@BOEHRINGER 16 Sep 2016 at 16:47
Dr. Jan Poth, Therapeutic Area Head Immunology
How does the disease restrict your daily life?
Central Nervous System
Dr. Juergen Reess, Therapeutic Area Head CNS
Drew Owenson, Therapeutic Area Head Respiratory at Boehringer Ingelheim
Dr. Glyn Parkin, Therapeutic Area Head Metabolic Diseases
Dr. Georg van Husen, Therapeutic Area Head Cardiovascular
Dr. Joerg Barth, Therapeutic Area Head Oncology
The Boehringer Ingelheim group of companies' objectives and beliefs can be summed up in a single phrase: Value through Innovation, the central concept of our corporate vision.
Watch Annelise, a systemic sclerosis patient, talk about how she coped with her diagnosis
New company video of Boehringer Ingelheim – Value through Innovation
@BOEHRINGER 11 Oct 2016 at 11:36
Making More Health
For new and better ways of improving health around the globe!
Finding out more about therapy goals in NSCLC
An introduction to the work we’ve been doing with physicians and patients
NSCLC prescribing behaviour survey
Professor Nicolas Girard, lead survey author, discusses what he found most interesting